- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Metabolic reprogramming of macrophages in the context of type 2 diabetes ; volume:29 ; number:1 ; day:16 ; month:10 ; year:2024 ; pages:1-10 ; date:12.2024
European journal of medical research ; 29, Heft 1 (16.10.2024), 1-10, 12.2024
- Creator
-
Witcoski Junior, Leonel
Lima, Jordana Dinorá de
Somensi, Amanda Girardi
Souza Santos, Lucas Brito de
Paschoal, Giulia Leonel
Uada, Thalita Suemy
Bastos, Thais Sibioni Berti
Paula, André Guilherme Portela de
Santos Luz, Rebeca Bosso Dos
Czaikovski, Andressa Pacheco
Davanso, Mariana Rodrigues
Braga, Tarcio Teodoro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40001-024-02069-y
- URN
-
urn:nbn:de:101:1-2501060953129.603860436217
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Witcoski Junior, Leonel
- Lima, Jordana Dinorá de
- Somensi, Amanda Girardi
- Souza Santos, Lucas Brito de
- Paschoal, Giulia Leonel
- Uada, Thalita Suemy
- Bastos, Thais Sibioni Berti
- Paula, André Guilherme Portela de
- Santos Luz, Rebeca Bosso Dos
- Czaikovski, Andressa Pacheco
- Davanso, Mariana Rodrigues
- Braga, Tarcio Teodoro
- SpringerLink (Online service)
Other Objects (12)
Glucocorticoid-induced immune-metabolic reprogramming in macrophages
Metabolic reprogramming of macrophages and its involvement in inflammatory diseases
Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming
Evaluating the potential of metabolic reprogramming of macrophages for glioblastoma therapy
Evaluating the potential of metabolic reprogramming of macrophages for glioblastoma therapy
Phosphorylation of PFKL regulates metabolic reprogramming in macrophages following pattern recognition receptor activation
Autophagic reprogramming of bone marrow–derived macrophages
Pharmacological reprogramming of macrophages through aptamiRs
Epigenetic reprogramming of macrophages in chronic diseases
Metabolic reprogramming in SIRT6-deficient hepatoblastoma cells and impact on anti-tumor response of macrophages
Metabolic Reprogramming of Macrophages Exposed to Silk, Poly (lactic‐ co ‐glycolic acid), and Silica Nanoparticles
Napabucasin-loaded PLGA nanoparticles trigger anti-HCC immune responses by metabolic reprogramming of tumor-associated macrophages
Glucocorticoid-induced immune-metabolic reprogramming in macrophages
Metabolic reprogramming of macrophages and its involvement in inflammatory diseases
Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming
Evaluating the potential of metabolic reprogramming of macrophages for glioblastoma therapy
Evaluating the potential of metabolic reprogramming of macrophages for glioblastoma therapy
Phosphorylation of PFKL regulates metabolic reprogramming in macrophages following pattern recognition receptor activation
Autophagic reprogramming of bone marrow–derived macrophages
Pharmacological reprogramming of macrophages through aptamiRs
Epigenetic reprogramming of macrophages in chronic diseases
Metabolic reprogramming in SIRT6-deficient hepatoblastoma cells and impact on anti-tumor response of macrophages
Metabolic Reprogramming of Macrophages Exposed to Silk, Poly (lactic‐ co ‐glycolic acid), and Silica Nanoparticles
Napabucasin-loaded PLGA nanoparticles trigger anti-HCC immune responses by metabolic reprogramming of tumor-associated macrophages
Glucocorticoid-induced immune-metabolic reprogramming in macrophages
Metabolic reprogramming of macrophages and its involvement in inflammatory diseases
Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming
Evaluating the potential of metabolic reprogramming of macrophages for glioblastoma therapy
Evaluating the potential of metabolic reprogramming of macrophages for glioblastoma therapy
Phosphorylation of PFKL regulates metabolic reprogramming in macrophages following pattern recognition receptor activation
Autophagic reprogramming of bone marrow–derived macrophages
Pharmacological reprogramming of macrophages through aptamiRs
Epigenetic reprogramming of macrophages in chronic diseases
Metabolic reprogramming in SIRT6-deficient hepatoblastoma cells and impact on anti-tumor response of macrophages
Metabolic Reprogramming of Macrophages Exposed to Silk, Poly (lactic‐ co ‐glycolic acid), and Silica Nanoparticles